TE1 fundamentals
An in-depth look to Bio Techne Corp. operating, investing, and financing activities
TE1 free cash flow for Q1 25 is 49.14 M EUR. For 2024, TE1 free cash flow was 220.43 M EUR and operating cash flow was 279.13 M EUR.
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
TTM